Literature DB >> 12010839

COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity.

David M Mannino1.   

Abstract

COPD continues to cause a heavy health and economic burden both in the United States and around the world. Some of the risk factors for COPD are well-known and include smoking, occupational exposures, air pollution, airway hyperresponsiveness, asthma, and certain genetic variations, although many questions, such as why < 20% of smokers develop significant airway obstruction, remain. Precise definitions of COPD vary and are frequently dependent on an accurate diagnosis of the problem by a physician. These differences in the definition of COPD can have large effects on the estimates of COPD in the population. Furthermore, evidence that COPD represents several different disease processes with potentially different interventions continues to emerge. In most of the world, COPD prevalence and mortality are still increasing and likely will continue to rise in response to increases in smoking, particularly by women and adolescents. Resources aimed at smoking cessation and prevention, COPD education and early detection, and better treatment will be of the most benefit in our continuing efforts against this important cause of morbidity and mortality.

Entities:  

Mesh:

Year:  2002        PMID: 12010839     DOI: 10.1378/chest.121.5_suppl.121s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  162 in total

1.  [Austrian Society for Pulmonary Diseases and Tuberculosis. Consensus concerning the management of chronic obstructive pulmonary diseases (COPD). Revised draft 2004].

Authors:  Lutz H Block; Otto C Burghuber; Sylvia Hartl; Hartmut Zwick
Journal:  Wien Klin Wochenschr       Date:  2004-04-30       Impact factor: 1.704

2.  Effect of upper extremity exercise in people with COPD.

Authors:  Ganesan Kathiresan; Senthil Kumar Jeyaraman; Jayachandran Jaganathan
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

3.  Inspiratory muscle training in patients with chronic obstructive pulmonary disease: the state of the evidence.

Authors:  Michael J Shoemaker; Sarah Donker; Ashley Lapoe
Journal:  Cardiopulm Phys Ther J       Date:  2009-09

4.  Whole-lung densitometry versus visual assessment of emphysema.

Authors:  Edoardo Cavigli; Gianna Camiciottoli; Stefano Diciotti; Ilaria Orlandi; Cheti Spinelli; Eleonora Meoni; Luca Grassi; Carmela Farfalla; Massimo Pistolesi; Fabio Falaschi; Mario Mascalchi
Journal:  Eur Radiol       Date:  2009-02-18       Impact factor: 5.315

5.  T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease.

Authors:  C Lambers; S Hacker; M Posch; K Hoetzenecker; A Pollreisz; M Lichtenauer; W Klepetko; H Jan Ankersmit
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

6.  Impact of haze and air pollution-related hazards on hospital admissions in Guangzhou, China.

Authors:  Zili Zhang; Jian Wang; Lianghua Chen; Xinyu Chen; Guiyuan Sun; Nanshan Zhong; Haidong Kan; Wenju Lu
Journal:  Environ Sci Pollut Res Int       Date:  2013-12-05       Impact factor: 4.223

7.  The Short-term Impact of Symptom-defined COPD Exacerbation Recovery on Health Status and Lung Function.

Authors:  Lindsey T Murray; Nancy K Leidy
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-24

8.  Effect of chronic obstructive pulmonary disease on swallowing function in stroke patients.

Authors:  Gun Woong Park; Suk Kyoung Kim; Chang Hwa Lee; Chung Reen Kim; Ho Joong Jeong; Dong Kyu Kim
Journal:  Ann Rehabil Med       Date:  2015-04-24

9.  Transitions regarding palliative and end-of-life care in severe chronic obstructive pulmonary disease or advanced cancer: themes identified by patients, families, and clinicians.

Authors:  Lynn F Reinke; Ruth A Engelberg; Sarah E Shannon; Marjorie D Wenrich; Elizabeth K Vig; Anthony L Back; J Randall Curtis
Journal:  J Palliat Med       Date:  2008-05       Impact factor: 2.947

Review 10.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.